Tubacex Valuation
Is TCX undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of TCX when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: TCX (€3.32) is trading below our estimate of fair value (€5.02)
Significantly Below Fair Value: TCX is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for TCX?
Key metric: As TCX is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is TCX's PE Ratio? | |
|---|---|
| PE Ratio | 18.2x |
| Earnings | €22.73m |
| Market Cap | €412.85m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 1.2x |
| Enterprise Value/EBITDA | 8.3x |
| PEG Ratio | 0.5x |
Price to Earnings Ratio vs Peers
How does TCX's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 12.9x | ||
EIS Eisen- und Hüttenwerke | 18.5x | n/a | €202.4m |
SIM0 SIMONA | 11.2x | n/a | €345.0m |
ACT AlzChem Group | 11.6x | 12.6% | €582.1m |
UZU Uzin Utz | 10.5x | 2.1% | €250.2m |
TCX Tubacex | 18.2x | 35.7% | €412.9m |
Price-To-Earnings vs Peers: TCX is expensive based on its Price-To-Earnings Ratio (18.2x) compared to the peer average (12.9x).
Price to Earnings Ratio vs Industry
How does TCX's PE Ratio compare vs other companies in the European Metals and Mining Industry?
| 14 Companies | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
| 14 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Earnings vs Industry: TCX is expensive based on its Price-To-Earnings Ratio (18.2x) compared to the European Metals and Mining industry average (11.1x).
Price to Earnings Ratio vs Fair Ratio
What is TCX's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 18.2x |
| Fair PE Ratio | 18.4x |
Price-To-Earnings vs Fair Ratio: TCX is good value based on its Price-To-Earnings Ratio (18.2x) compared to the estimated Fair Price-To-Earnings Ratio (18.4x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | €3.32 | €4.89 +47.5% | 11.0% | €5.54 | €4.00 | n/a | 6 |
| Nov ’25 | €3.18 | €4.82 +51.7% | 12.5% | €5.54 | €4.00 | n/a | 6 |
| Oct ’25 | €3.32 | €4.82 +45.3% | 12.5% | €5.54 | €4.00 | n/a | 6 |
| Sep ’25 | €2.93 | €4.99 +70.5% | 10.5% | €5.54 | €4.10 | n/a | 5 |
| Aug ’25 | €2.85 | €4.99 +75.3% | 10.5% | €5.54 | €4.10 | n/a | 5 |
| Jul ’25 | €3.26 | €4.84 +48.6% | 9.9% | €5.54 | €4.10 | n/a | 5 |
| Jun ’25 | €3.31 | €4.84 +46.4% | 9.9% | €5.54 | €4.10 | n/a | 5 |
| May ’25 | €3.14 | €4.78 +52.2% | 10.2% | €5.54 | €4.10 | n/a | 5 |
| Apr ’25 | €3.32 | €4.78 +44.1% | 10.2% | €5.54 | €4.10 | n/a | 5 |
| Mar ’25 | €3.35 | €4.78 +42.6% | 10.2% | €5.54 | €4.10 | n/a | 5 |
| Feb ’25 | €3.39 | €4.67 +38.0% | 7.3% | €5.05 | €4.10 | n/a | 5 |
| Jan ’25 | €3.59 | €4.69 +30.6% | 7.3% | €5.05 | €4.10 | n/a | 5 |
| Dec ’24 | €3.39 | €4.69 +38.3% | 7.3% | €5.05 | €4.10 | n/a | 5 |
| Nov ’24 | €2.81 | €4.65 +65.5% | 7.5% | €5.05 | €4.10 | €3.18 | 5 |
| Oct ’24 | €3.07 | €4.59 +49.5% | 8.2% | €5.05 | €4.10 | €3.32 | 5 |
| Sep ’24 | €2.85 | €4.48 +57.0% | 7.5% | €5.00 | €4.10 | €2.93 | 4 |
| Aug ’24 | €2.90 | €4.48 +54.3% | 7.5% | €5.00 | €4.10 | €2.85 | 4 |
| Jul ’24 | €2.72 | €3.98 +46.4% | 8.4% | €4.50 | €3.60 | €3.26 | 4 |
| Jun ’24 | €2.51 | €3.88 +54.4% | 9.5% | €4.50 | €3.60 | €3.31 | 4 |
| May ’24 | €2.51 | €3.88 +54.4% | 9.5% | €4.50 | €3.60 | €3.14 | 4 |
| Apr ’24 | €2.44 | €3.64 +49.1% | 11.1% | €4.30 | €3.25 | €3.32 | 4 |
| Mar ’24 | €2.45 | €3.59 +46.7% | 11.6% | €4.30 | €3.25 | €3.35 | 4 |
| Feb ’24 | €2.42 | €3.56 +47.2% | 12.0% | €4.30 | €3.25 | €3.39 | 4 |
| Jan ’24 | €1.95 | €3.61 +85.4% | 13.1% | €4.30 | €3.10 | €3.59 | 4 |
| Dec ’23 | €2.02 | €3.61 +79.3% | 13.1% | €4.30 | €3.10 | €3.39 | 4 |
| Nov ’23 | €2.18 | €3.61 +66.1% | 13.1% | €4.30 | €3.10 | €2.81 | 4 |
Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.
Discover undervalued companies
Central Asia Metals
UK£282.2m
Operates as a base metals producer.
9C3
UK£1.90
7D
1.1%
1Y
0.5%
Minerals Technologies
US$2.6b
Develops, produces, and markets various mineral, mineral-based, and related systems and services.
MNK
US$74.50
7D
1.4%
1Y
33.0%
Cabka
€60.3m
Manufactures and sells pallets and large containers made from recycled plastic in Europe, North America, and internationally.
7GW
€2.38
7D
-7.8%
1Y
-61.1%